EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma

The use of daratumumab in combination with established regimens for the treatment of newly diagnosed multiple myeloma has recently been authorized by the European Medicines Agency based on results from three separate phase III randomized, active controlled, open‐label studies that have confirmed enh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Michaleas, Sotirios, Penninga, Elisabeth, Hovgaard, Doris, Dalseg, Anne‐Marie, Rosso, Aldana, Sarac, Sinan B., Jimenez, Jorge Camarero, Fernández, Lucia López‐Anglada, Fernández, Carolina Prieto, Mangas‐SanJuan, Victor, Garcia, Isabel, Payares‐Herrera, Concepcion, Sancho‐López, Aranzazu, Enzmann, Harald, de Castro Lopes Silva, Marcia Sofia Sanches, Duarte, Sílvia, Pignatti, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Regulatory Issues: EMA
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938407/
https://ncbi.nlm.nih.gov/pubmed/33026700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados